U.S. Markets open in 7 mins

Novartis says no intention of pursuing Actavis, Bloomberg reports

Novartis (NVS) told Bloomberg it has no intention of pursuing a takeover of Actavis (ACT) after the Wall Street Journal reported last night that it was considering a possible bid for the generic drug maker.